In another study, n-3 PUFAs supplementation combined with lycopene and rosuvastatin lowered the plasma IL-6 levels and reverted the leukotriene B4 receptor gene expression to baseline levels in COPD patients [124]. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.